Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7611839 Methods for diagnosing RCC and other solid tumors

Patent 7611839 was granted and assigned to Wyeth on November, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

William L. Trepicchio0

Andrew J. Dorner0

Donna K. Slonim0

Jennifer A. Stover0

Michael E. Burczynski0

Natalie C. Twine0

Date of Patent

November 3, 2009

0

Patent Application Number

107175970

Date Filed

November 21, 2003

0

Patent Citations Received

US Patent 11802874 PD-ECGF as biomarker of cancer

US Patent 11776664 Method to use gene expression to determine likelihood of clinical outcome of renal cancer

Patent Primary Examiner

0

Patent abstract

Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7611839 Methods for diagnosing RCC and other solid tumors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.